These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12420668)

  • 1. Myocardial enhancement on magnetic resonance imaging with gadolinium-diethylenetriamine pentaacetic acid and improvement of left ventricular function in patients with dilated cardiomyopathy.
    Akisawa M; Matsumura Y; Kitaoka H; Yamasaki N; Takata J; Doi Y
    J Cardiol; 2002 Oct; 40(4):145-52. PubMed ID: 12420668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
    Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
    J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive determination of regional myocardial perfusion with first-pass magnetic resonance (MR) imaging.
    Nakajima T; Oriuchi N; Tsushima Y; Funabasama S; Aoki J; Endo K
    Acad Radiol; 2004 Jul; 11(7):802-8. PubMed ID: 15217598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gadolinium-diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging of dilated cardiomyopathy: clinical significance of abnormally high signal intensity of left ventricular myocardium].
    Koito H; Suzuki J; Ohkubo N; Ishiguro Y; Iwasaka T; Inada M
    J Cardiol; 1996 Jul; 28(1):41-9. PubMed ID: 8768505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
    Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
    Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced cardiovascular magnetic resonance in primary and ischemic dilated cardiomyopathy.
    Calore C; Cacciavillani L; Boffa GM; Silva C; Tiso E; Marra MP; Bacchiega E; Corbetti F; Iliceto S
    J Cardiovasc Med (Hagerstown); 2007 Oct; 8(10):821-9. PubMed ID: 17885521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
    Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance.
    Soriano CJ; Ridocci F; Estornell J; Jimenez J; Martinez V; De Velasco JA
    J Am Coll Cardiol; 2005 Mar; 45(5):743-8. PubMed ID: 15734620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
    Masci PG; Schuurman R; Andrea B; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of myocardial blood flow reserve in idiopathic dilated cardiomyopathy without overt heart failure and its relation with functional indices: an echo-Doppler and positron emission tomography study.
    Morales MA; Neglia D; L'Abbate A
    J Cardiovasc Med (Hagerstown); 2008 Aug; 9(8):778-82. PubMed ID: 18607240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging assessment of reverse left ventricular remodeling late after restrictive mitral annuloplasty in early stages of dilated cardiomyopathy.
    Westenberg JJ; Braun J; Van de Veire NR; Klautz RJ; Versteegh MI; Roes SD; van der Geest RJ; de Roos A; van der Wall EE; Reiber JH; Bax JJ; Dion RA
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1247-52; discussion 1252-3. PubMed ID: 18544363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between liver function and liver signal intensity in hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging.
    Tajima T; Takao H; Akai H; Kiryu S; Imamura H; Watanabe Y; Shibahara J; Kokudo N; Akahane M; Ohtomo K
    J Comput Assist Tomogr; 2010; 34(3):362-6. PubMed ID: 20498536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in gadolinium-DTPA enhanced magnetic resonance signal intensity ratio in hypertrophic cardiomyopathy].
    Tsukihashi H; Ishibashi Y; Shimada T; Hatano J; Tanabe K; Ooyake N; Morioka S; Moriyama K
    J Cardiol; 1994; 24(3):185-91. PubMed ID: 8207632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.
    Tamada T; Ito K; Sone T; Yamamoto A; Yoshida K; Kakuba K; Tanimoto D; Higashi H; Yamashita T
    J Magn Reson Imaging; 2009 Mar; 29(3):636-40. PubMed ID: 19243060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse late gadolinium enhancement by cardiovascular magnetic resonance predicts significant intraventricular systolic dyssynchrony in patients with non-ischemic dilated cardiomyopathy.
    Tigen K; Karaahmet T; Kirma C; Dundar C; Pala S; Isiklar I; Cevik C; Kilicgedik A; Basaran Y
    J Am Soc Echocardiogr; 2010 Apr; 23(4):416-22. PubMed ID: 20149594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of late gadolinium enhancement is associated with increased left ventricular wall stress and mass in patients with non-ischaemic dilated cardiomyopathy.
    Alter P; Rupp H; Adams P; Stoll F; Figiel JH; Klose KJ; Rominger MB; Maisch B
    Eur J Heart Fail; 2011 Sep; 13(9):937-44. PubMed ID: 21803756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed hyperenhancement magnetic resonance imaging is useful in predicting functional recovery of nonischemic left ventricular systolic dysfunction.
    Park S; Choi BW; Rim SJ; Shim CY; Ko YG; Kang SM; Ha JW; Jang Y; Chung N; Choe KO; Cho SY
    J Card Fail; 2006 Mar; 12(2):93-9. PubMed ID: 16520255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging.
    Gao P; Yee R; Gula L; Krahn AD; Skanes A; Leong-Sit P; Klein GJ; Stirrat J; Fine N; Pallaveshi L; Wisenberg G; Thompson TR; Prato F; Drangova M; White JA
    Circ Cardiovasc Imaging; 2012 Jul; 5(4):448-56. PubMed ID: 22572740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of left ventricular response to isoproterenol infusion in patients with dilated cardiomyopathy.
    Yukisada K; Iida K; Sugishita Y; Ito I
    J Cardiol; 1987 Dec; 17(4):749-58. PubMed ID: 3506601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dilated myocardiopathies: the relationship between the degree of cardiac dysfunction and ventricular arrhythmias. A clinical follow-up].
    Abreu A; Pereira H; Catarino C; Branco L; Valério L; Nunes H; Gonçalves JM; Gracias R; Antunes AM
    Rev Port Cardiol; 1993 Jan; 12(1):8, 33-7. PubMed ID: 8517976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.